跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Blirelin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Blirelin
Approved
STANDARD
Blirelin
Dongkook Pharmaceutical Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
0cfc0950209bcb2c
Company
Dongkook Pharmaceutical Co., Ltd.
Type
Standard
Approval Details
Approval Id
0cfc0950209bcb2c
Drug Approval Philippines Name
Blirelin
Product Name
Blirelin
Registration Number
DRP-13946
Brand Name
Blirelin
Generic Name
Leuprolide Acetate
Dosage Form
Powder For Injection (IM/SC)
Dosage Strength
3.75mg
Manufacturer
Dongkook Pharmaceutical Co., Ltd.
Importer
Bliss Pharma Distribution and Consultancy Corp.
Distributor
Bliss Pharma Distribution and Consultancy Corp.
Company Detail Path
/organization/dongkook-pharmaceutical-co-ltd
Issuance Date
23 May 2023
Expiry Date
23 May 2028
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
0cfc0950209bcb2c
Type
Standard
Back to Philippines FDA Approvals